Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), and Subcommittee for Dose Reconstruction Reviews (SDRR), 71914-71915 [E7-24644]
Download as PDF
<![CDATA[
71914
Federal Register / Vol. 72, No. 243 / Wednesday, December 19, 2007 / Notices
Atlanta, Georgia 30337, Telephone (770)
997–1100.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review, discussion, and
evaluation of ‘‘Field Trails to Evaluate
Efficacy of Natural Products for the
Control of the Tick Vectors of Lyme
Disease Spirochetes, FOA Number
CK08–001; Evaluation of ReservoirTargeted Vaccine Formulations to
Prevent Enzootic Transmission of
Borrelia Burgdorferi (Lyme Borreliosis),
FOA Number CK08–002.’’
Contact Person for More Information:
Shoukat Qari, D.V.M., Ph.D., Scientific
Review Administrator, Strategic Science
and Program Unit, Office of the Director,
Coordinating Center for Infectious
Diseases, CDC, 1600 Clifton Road,
Mailstop C–19, Atlanta, GA, Telephone
(404) 639–8942.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: December 12, 2007.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E7–24643 Filed 12–18–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC66 with NOTICES
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH), and Subcommittee for Dose
Reconstruction Reviews (SDRR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned committee and
subcommittee:
Subcommittee Meeting Time and Date
10 a.m.–12:30 p.m., January 8, 2008
VerDate Aug<31>2005
21:40 Dec 18, 2007
Jkt 214001
Advisory Board Meeting Times and
Dates
1 p.m.–4:30 p.m., January 8, 2008
9:30 a.m.–5 p.m., January 9, 2008
8:30 a.m.–2:30 p.m., January 10, 2008
Public Comment Times and Dates
5 p.m.–6 p.m., January 8, 2008
7:30 p.m.–8:30 p.m., January 9, 2008
Place: Suncoast Hotel and Casino,
9090 Alta Drive, Las Vegas, NV 89145.
Phone 702.636.7111, Fax 702.636.7050.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 75
to 100 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program (EEOICP) Act of 2000 to advise
the President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2009.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Discussed: The topics
for the Subcommittee meeting will
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
include a Review of Individual Dose
Reconstructions and future
Subcommittee Plans and Actions. The
agenda for the Advisory Board meeting
includes: NIOSH Program Status Report;
Redaction of Board Transcripts and SEC
Petition for Texas City Chemicals, Inc.;
SEC Petition for Nevada Test Site; SEC
Petition for Mound; SEC Petition for
Combustion Engineering; SEC Petition
for Lawrence Livermore National
Laboratory; SEC Petition Updates:
Bethlehem Steel, Blockson, Chapman
Valve, Dow Chemical, Fernald, and
Sandia; Science Issues Update;
Department of Labor Update;
Department of Energy Update; FY08
Tasks for Sanford Cohen & Associates;
Update on selection of board support
contractor; NIOSH Program Update;
Board Future Plans and Schedules;
Working Group Reports; and a
Subcommittee for Dose Reconstruction
Reviews Report. The agenda is subject
to change as priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted according the policy
provided below. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment)
(1) If a person making a comment
gives his or her name, no attempt will
be made to redact that name. (2) NIOSH
will take reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public website. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comment; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and the Federal
E:\FR\FM\19DEN1.SGM
19DEN1
Federal Register / Vol. 72, No. 243 / Wednesday, December 19, 2007 / Notices
Advisory Committee Act and if deemed
appropriate, will redact such
information. (4) All disclosures of
information concerning third parties
will be redacted. (5) If it comes to the
attention of the DFO that an individual
wishes to share information with the
Board but objects to doing so in a public
forum, the DFO will work with that
individual, in accordance with the
Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Dr. Lewis V. Wade, Executive Secretary,
NIOSH, CDC, 4676 Columbia Parkway,
Cincinnati, Ohio 45226, Phone
513.533.6825, Fax 513.533.6826.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: December 12, 2007.
Elaine L. Baker,
Director, Management Analysis and Services
Office,Centers for Disease Control and
Prevention.
[FR Doc. E7–24644 Filed 12–18–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on PROD1PC66 with NOTICES
Board of Scientific Counselors,
National Center for Health Statistics
(NCHS)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the CDC announces
the following meeting of the
aforementioned committee:
Times and Dates: 11 a.m.–5:30 p.m.,
January 23, 2008. 8:30 a.m.–2 p.m.,
January 24, 2008.
Place: NCHS Headquarters, 3311
Toledo Road, Hyattsville, Maryland
20782.
Status: This meeting is open to the
public; however, visitors must be
processed in accordance with
established federal policies and
procedures. For foreign nationals or
non-US citizens, pre-approval is
required (please contact Althelia Harris,
301–458–4261, adw1@cdc.gov or
Virginia Cain, vcain@cdc.gov at least 10
days in advance for requirements). All
visitors are required to present a valid
form of picture identification issued by
a state, federal or international
VerDate Aug<31>2005
21:40 Dec 18, 2007
Jkt 214001
government. As required by the Federal
Property Management Regulations, Title
41, Code of Federal Regulations, subpart
101–20.301, all persons entering in or
on Federal controlled property and their
packages, briefcases, and other
containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. The meeting room
accommodates approximately 100
people.
Purpose: This committee is charged
with providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NCHS, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters To Be Discussed: The agenda
will include welcome remarks by the
Director, NCHS; review of the State and
Local Area Integrated Telephone Survey
program; presentation of the National
Health Interview Survey program;
discussion of upcoming program
reviews and an open session for
comments from the public.
Requests to make oral presentations
should be submitted in writing to the
contact person listed below. All requests
must contain the name, address,
telephone number, and organizational
affiliation of the presenter.
Written comments should not exceed
five single-spaced typed pages in length
and must be received by January 9,
2008.
The agenda items are subject to
change as priorities dictate.
Contact Person for More Information:
Virginia S. Cain, Ph.D., Director of
Extramural Research, NCHS/CDC, 3311
Toledo Road, Room 7211, Hyattsville,
Maryland 20782, telephone (301) 458–
4500, fax (301) 458–4020.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: December 12, 2007.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E7–24642 Filed 12–18–07; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
71915
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2273–N]
RIN 0938–AO99
State Children’s Health Insurance
Program (SCHIP); Additional
Allotments To Eliminate FY 2007
Funding Shortfalls
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This notice describes the
methodology and process we are using
for determining the amounts of certain
States’ remaining SCHIP funding
shortfalls in Federal fiscal year (FY)
2007, in accordance with the provisions
of the U.S. Troop Readiness, Veteran’s
Care, Katrina Recovery, and Iraq
Accountability Appropriations Act,
2007. This notice also contains the
amounts of the additional allotments to
be provided to such States to eliminate
such FY 2007 funding shortfalls,
determined in accordance with this
methodology.
FOR FURTHER INFORMATION CONTACT:
Richard Strauss, (410) 786–2019.
SUPPLEMENTARY INFORMATION:
I. Background
A. Availability and Redistribution of
SCHIP Fiscal Year Allotments
Title XXI of the Social Security Act
(the Act) sets forth the State Children’s
Health Insurance Program (SCHIP) to
enable States, the District of Columbia,
and specified Commonwealths and
Territories to initiate and expand health
insurance coverage to uninsured, lowincome children. The 50 States, the
District of Columbia, and the
Commonwealths and Territories may
implement the SCHIP through a
separate child health program under
title XXI of the Act, an expanded
program under title XIX of the Act, or
a combination of both.
Section 2104(e) of the Act specifies
that the SCHIP allotments for a Federal
fiscal year are available for payment to
States for their expenditures under an
approved State child health plan for an
initial 3-fiscal year period of
availability, including the fiscal year for
which the allotment was provided.
Section 2104(f) of the Act specifies that
the amounts of States’ allotments which
are not expended during the initial 3year period of availability are to be
redistributed to those States that have
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 72, Number 243 (Wednesday, December 19, 2007)]
[Notices]
[Pages 71914-71915]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-24644]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH),
and Subcommittee for Dose Reconstruction Reviews (SDRR)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC announces the following meeting
of the aforementioned committee and subcommittee:
Subcommittee Meeting Time and Date
10 a.m.-12:30 p.m., January 8, 2008
Advisory Board Meeting Times and Dates
1 p.m.-4:30 p.m., January 8, 2008
9:30 a.m.-5 p.m., January 9, 2008
8:30 a.m.-2:30 p.m., January 10, 2008
Public Comment Times and Dates
5 p.m.-6 p.m., January 8, 2008
7:30 p.m.-8:30 p.m., January 9, 2008
Place: Suncoast Hotel and Casino, 9090 Alta Drive, Las Vegas, NV
89145. Phone 702.636.7111, Fax 702.636.7050.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 75 to 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2009.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Discussed: The topics for the Subcommittee meeting
will include a Review of Individual Dose Reconstructions and future
Subcommittee Plans and Actions. The agenda for the Advisory Board
meeting includes: NIOSH Program Status Report; Redaction of Board
Transcripts and SEC Petition for Texas City Chemicals, Inc.; SEC
Petition for Nevada Test Site; SEC Petition for Mound; SEC Petition for
Combustion Engineering; SEC Petition for Lawrence Livermore National
Laboratory; SEC Petition Updates: Bethlehem Steel, Blockson, Chapman
Valve, Dow Chemical, Fernald, and Sandia; Science Issues Update;
Department of Labor Update; Department of Energy Update; FY08 Tasks for
Sanford Cohen & Associates; Update on selection of board support
contractor; NIOSH Program Update; Board Future Plans and Schedules;
Working Group Reports; and a Subcommittee for Dose Reconstruction
Reviews Report. The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted according the policy provided below. Any written comments
received will be provided at the meeting and should be submitted to the
contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment)
(1) If a person making a comment gives his or her name, no attempt
will be made to redact that name. (2) NIOSH will take reasonable steps
to ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public website. Such reasonable
steps include: (a) A statement read at the start of each public comment
period stating that transcripts will be posted and names of speakers
will not be redacted; (b) A printed copy of the statement mentioned in
(a) above will be displayed on the table where individuals sign up to
make public comment; (c) A statement such as outlined in (a) above will
also appear with the agenda for a Board Meeting when it is posted on
the NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals personal
information (e.g., medical information) about themselves that
information will not usually be redacted. The NIOSH FOIA coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and the Federal
[[Page 71915]]
Advisory Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the DFO
that an individual wishes to share information with the Board but
objects to doing so in a public forum, the DFO will work with that
individual, in accordance with the Federal Advisory Committee Act, to
find a way that the Board can hear such comments.
Contact Person for More Information: Dr. Lewis V. Wade, Executive
Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226,
Phone 513.533.6825, Fax 513.533.6826.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: December 12, 2007.
Elaine L. Baker,
Director, Management Analysis and Services Office,Centers for Disease
Control and Prevention.
[FR Doc. E7-24644 Filed 12-18-07; 8:45 am]
BILLING CODE 4163-18-P
